STAT

Get ready for STAT Madness 2018

STAT Madness is fundamentally a celebration of science. It starts Monday.

What does great biomedical science look like? Is it an advance in cancer therapy? A device that helps people recover from injury faster? Or, is it an inexpensive tool that gives developing nations a chance to fight crippling disease?

Great bioscience looks like all of this, and those examples are among the nearly 150 entries you sent us for STAT Madness, our yearly contest to find the next best innovations in health and medicine.

Starting Monday, we’ll seed a single-elimination bracket of 64 entries that will give us a crowd-voted favorite. (Click for last year’s

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About AstraZeneca CEO Pay, Alternatives To WuXi And More
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.

Related Books & Audiobooks